The expression and function of G-proteins in experimental intimal hyperplasia.
G-proteins are membrane-bound signal transduction proteins which couple extracellular receptor signals to various effectors. This study examines the expression and the function of G-proteins (alpha i, alpha s, alpha q, and alpha o) in experimental intimal hyperplasia. Vein bypass grafts were placed in 30 New Zealand White rabbits and were harvested after 28 d. The contralateral jugular veins served as controls. Isometric tension studies were performed on rings from veins and vein grafts (n = 10), and Western blot and mRNA analyses were performed in another 20 vessels. There was a fivefold increase in alpha q, a 2.7-fold increase in the alpha i2, and a 3.3-fold increase in alpha s expressions in vein grafts compared with veins. Detectable expression of alpha i3 was observed in vein grafts but not in jugular veins. In addition, there was a 3.8-fold increase in beta subunits in the vein grafts compared with the veins. mRNA for alpha s, alpha i3, and alpha i2 were all elevated in the vein grafts. No detectable levels of the alpha i1 protein or its mRNA were present in either veins or vein grafts. Contractile responses in the veins were not inhibited by pertussis toxin. The contractile responses to norepinephrine were enhanced by twofold, and the responses to serotonin developed de novo in vein grafts compared with veins. The contractile responses to both norepinephrine and serotonin were only partially inhibited by pertussis toxin in the vein grafts even though there was 100% ADP ribosylation with pertussis toxin in both veins and vein grafts. These data suggest that intimal hyperplasia is associated with increased or novel expression of G-proteins in vivo which occur simultaneously with the development of pertussis toxin-sensitive contractile responses. Changes in G-proteins at a transcriptional level or at the level of RNA stability may be involved in the response of smooth muscle cells to injury and to intimal hyperplasia formation.
Davies
M G
MG
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.
Ramkumar
V
V
Gettys
T W
TW
Hagen
P O
PO
D000535:Aluminum / Q000494:pharmacology; D000818:Animals; D017536:Carotid Artery, Common / Q000378:metabolism; D005461:Fluorine / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D006965:Hyperplasia / Q000378:metabolism / Q000473:pathology; D007537:Isometric Contraction / Q000187:drug effects; D007601:Jugular Veins / Q000378:metabolism* / Q000473:pathology / Q000502:physiology / Q000637:transplantation; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D037342:Pertussis Toxin; D012333:RNA, Messenger / Q000096:biosynthesis; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D014158:Transcription, Genetic; D017539:Tunica Intima / Q000378:metabolism* / Q000473:pathology; D014654:Vascular Patency; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D012333:RNA, Messenger; D010566:Virulence Factors, Bordetella; C053629:fluoroaluminum; D005461:Fluorine; D012701:Serotonin; D000535:Aluminum; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D009638:Norepinephrine